Description:
What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the cell and gene therapy industry is marked by advances in science and the standardization of manufacturing and commercialization of products. These therapies are transforming treatments for cancers and genetic diseases, and expanding into other areas such as autoimmune, cardiovascular, musculoskeletal, and dermatological diseases.
Cell Therapy and Gene Therapy Markets, 2020 contains the following important data points:
- Market Estimates and Forecasts, 2020-2030
- Breakdown by Product Segment, Method, and Geographic Region
- Competitive Summary of Leading Providers
- Distribution by Product Segment in the US and Europe
- Estimated Sales by Leading Competitors
Key Highlights:
This report presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and a competitive summary of leading providers. The data includes:
- Cell and Gene Therapy Market Summary by Product Segment (Dermatological, Cardiovascular-Blood, Oncology, Ophthalmic, Musculoskeletal, Other Conditions)
- Cell and Gene Therapy Market Summary by Method (Cell Therapy, Gene Therapy)
- Cell and Gene Therapy Market Summary by Geographical Region (United States, Europe/European Union, Other Countries, Global Market)
- U.S. Cell and Gene Therapy Market Distribution by Product Segment
- Europe Cell and Gene Therapy Market Distribution by Product Segment
- Other Countries Cell and Gene Therapy Market Distribution by Product Segment
- Estimated Cell and Gene Therapy Sales by Leading Competitors, 2019
Leading Influencers:
The leading influencers in the market are those first-to-market participants, companies with new developments disrupting current market conditions, and those with extensive pipelines poised to impact the market long-term.
Detailed Market Analysis:
The report examines developments in cell and gene therapy markets by condition/disorder, including principal products, trends in research and development, market breakdowns, regional market summaries, and competitor summaries. Conditions and disorders covered include:
- Dermatology:
- Market by Product Type and General Indication
- Market by Country/Region
- Competitor Market Share
- Cardiovascular and Blood Disorders:
- Market by Product Type and General Indication
- Market Summary by Geographic Region
- Oncology:
- Market by Product Type and General Indication
- Market Summary by Geographic Region
- Competitor Market Share
- Ophthalmic Conditions:
- Market by Product Type
- Market Summary by Geographic Region
- Musculoskeletal Conditions and Disorders:
- Market by General Indication
- Market by Country/Region
- Competitor Market Share
- Other Conditions:
- Market by Product Type
- Market by Country/Region
Additional Insights:
Cell Therapy and Gene Therapy Markets, 2020 includes discussions on therapies in development and their expected market impact. The report addresses market indicators, trends, and barriers, providing comprehensive insights into this transformative field.
Explore the full report to understand the current landscape and future opportunities in the cell and gene therapy market, and gain a competitive edge in this rapidly evolving industry.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Oncology Cell and Gene Therapy Market by General Indication, Estimated 2020, Projected 2025 and 2030 ($ millions)
| Product Segment | 2020 $ | 2025 $ | 2030 $ |
| Blood cancers | $XX Million | $XX Million | $XX Million |
| Prostate cancer | $XX Million | $XX Million | $XX Million |
| Melanoma | $XX Million | $XX Million | $XX Million |
| Other cancers | $XX Million | $XX Million | $XX Million |
Source: Kalorama Information
